Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Management of hyperlipidemias: An update
Indian Journal of Dermatology, Venereology and Leprology , 09/14/09
Ranjan N et al. – The discovery of the key enzymes, receptors, and transporters in cholesterol biosynthesis has enabled us to assemble fragments of knowledge concerning lipids and lipoproteins into dynamic pathways, leading to the development of a multitude of lipid–lowering drugs. After a brief recapitulation of the pathways of cholesterol metabolism and the dermatologic manifestations of lipid derangement, the authors shall review drugs which modify intestinal cholesterol and bile–acid reabsorption, and hepatic lipoprotein biosynthesis and catabolism.
Related Articles
Familial Combined Hyperlipidemia Is Associated With Alterations in the Cholesterol Synthesis Pathway
Arteriosclerosis, Thrombosis, and Vascular Biology, 10/20/09
Relevance Score: 82%
Prevalence of myocardial infarction in patients with psoriasis in central China
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 80%
Stroke in HIV infection and AIDS
Expert Review of Cardiovascular Therapy, 10/16/09
Relevance Score: 80%
Emotional Changes in Men Treated With Sildenafil Citrate for Erectile Dysfunction a Double-Blind, Placebo-Controlled Clinical Trial
The Journal of Sexual Medicine, 10/07/09
Relevance Score: 80%
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
Modern Rheumatology, 10/05/09
Relevance Score: 80%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Carotid Intima-Media Thickness: Knowledge and Application to Everyday Practice
Postgraduate Medicine, 11/25/09
Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C2C12 myotubes
Endocrinology and Metabolism, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


